$1.40
-0.09 (-6.04%)
RGNT News3 articles
Regentis Biomaterials Shares Retreat After Record Surge on Withdrawal of Share Offering
Regentis Biomaterials shares dropped 27.66% premarket after a 506% surge driven by the withdrawal of a planned share offering, with investors focusing on upcoming surgeon training and funding concerns.
Regentis Shares Surge After Withdrawing U.S. Share Offering
RGNT surged up to 850% after Regentis withdrew its U.S. share offering, easing dilution fears but leaving funding concerns amid a $13.6 million loss and going concern warning.
Regentis Biomaterials Stock: Surgeon Training for GelrinC Knee Implant Set for Q3
Regentis Biomaterials shares fell slightly premarket after announcing European surgeon training for its GelrinC knee implant will start in Q3, a commercial milestone but not yet revenue.